Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of value gouging, declaring the stark distinction among U.S. selling prices and those in Europe and copyright.Thank you for reaching out! Our workforce will evaluation your inquiry and have back to you at t